This is a working overview of pharmacokinetics, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-04. Anything still debated is marked as such rather than presented as settled.
Early work on melanocortin analogs in the 1980s and 1990s produced peptides intended to influence pigmentation and appetite. One of these, melanotan II, was observed to affect sexual desire as an incidental finding in self-administration reports. Researchers then pursued analogs with altered receptor selectivity and improved handling characteristics, and PT-141 emerged from that program in the late 1990s. The development path moved from dermatology and metabolism toward a central nervous system application, a shift that shaped both trial designs and the eventual label.
Regulatory review of bremelanotide concluded in 2019 with approval in the United States for a defined indication in premenopausal women. The reviewed formulation is a single-use prefilled autoinjector given subcutaneously, and its label carries cardiovascular monitoring language tied to blood pressure changes recorded during trials. Availability outside the approving jurisdiction varies, and in several countries the compound remains unapproved or is handled as a prescription-only item. Compounded and research-grade material also circulates, and it differs from the reviewed product in purity, characterization, and chain of custody.
The compound binds several melanocortin receptor subtypes rather than a single target, with the strongest functional activity reported at MC4R and measurable activity at MC1R, MC3R and MC5R. MC4R populations are dense in hypothalamic nuclei that integrate energy balance, autonomic tone and reproductive behaviour, which is the anatomical basis for the proposed pro-desire effect. Because binding is not subtype-selective, pigmentary and vascular effects accompany central activity. Improving subtype selectivity is an active area of analogue design. Direct causal mapping from receptor occupancy to reported desire change in humans is not fully established.
After subcutaneous dosing, peak plasma concentrations appear within roughly one hour, and elimination is fast, with a half-life on the order of a few hours. Degradation is mainly proteolytic, and at least one circulating fragment retains receptor activity, so parent-drug levels alone do not describe total exposure. Clearance does not depend heavily on hepatic cytochrome enzymes, which lowers the likelihood of common metabolic interaction routes. Data in renal or hepatic impairment are limited. Repeated dosing does not appear to produce marked accumulation given the short half-life.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Cyclic heptapeptide core |
| Molecular weight | 1025.2 g/mol | Calculated for the free base |
| CAS registry number | 189691-06-3 | Free base; the acetate salt has a separate entry |
| Solubility class | Water-soluble | Freely soluble in aqueous media near neutral pH |
| Typical storage | 2 to 8 °C | Protect from light; avoid repeated freeze-thaw cycles |
PT-141 is a synthetic cyclic heptapeptide whose development code is bremelanotide. It belongs to the class of melanocortin receptor agonists and acts by mimicking endogenous peptide hormones. The compound originated from research on melanotan II, where investigators exploring derivatives found distinct pharmacological features. Unlike the parent compound, PT-141 showed effects on pathways related to sexual desire and function in early studies, prompting its development as a separate candidate. Its molecular design aimed to separate receptor activity from pigmentary effects.
The molecular backbone consists of seven amino acid residues joined into a ring through a disulfide bridge. This cyclic conformation is critical for receptor binding. The sequence includes an acetylated N-terminus and an amidated C-terminus, modifications that improve resistance to enzymatic breakdown. One residue is in the D-configuration, a feature that further stabilizes the peptide against protease activity. Together, the ring structure and specific stereochemistry determine selectivity among melanocortin receptor subtypes.
Across literature and commercial listings, the substance appears under several names, including bremelanotide, PT-141, and various brand designations. A CAS registry number provides a unique identifier for the compound, aiding retrieval from chemical databases. Synonym lists may also contain early development codes and descriptive chemical names. When consulting sources, researchers need to confirm that the cited names refer to the same molecular structure to avoid confusion. Naming consistency matters especially when comparing analytical data across publications.
Bremelanotide is a cyclic heptapeptide that acts as an agonist at melanocortin receptors. It binds MC1R, MC3R, MC4R, and MC5R, with MC4R activation considered most relevant to sexual desire pathways in the central nervous system. The molecule is a synthetic analog of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and energy regulation. Early research explored its use in tanning before attention shifted toward sexual dysfunction applications. Receptor binding affinity varies across these subtypes.
Activation of MC4R in the hypothalamus is thought to influence dopaminergic signaling, which in turn affects arousal and desire. This mechanism differs from that of phosphodiesterase type 5 inhibitors, which act primarily on vascular smooth muscle in the genital region. Because the pathway is central rather than peripheral, effects are not strictly dependent on local blood flow. The precise downstream cascade linking receptor binding to behavioral outcomes remains an area of ongoing investigation.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
Bremelanotide acts as an agonist at several melanocortin receptors, with the strongest reported activity at MC4R and measurable activity at MC1R and MC3R. Because MC4R is expressed in hypothalamic and limbic circuits, the proposed mechanism links receptor activation to modulation of central pathways involved in desire rather than to direct effects on peripheral genital tissue. The precise downstream steps remain incompletely characterized, and evidence for the involvement of specific neurotransmitters is suggestive rather than settled. Nausea and blood pressure elevation reported during trials are consistent with melanocortin signaling outside the intended target circuit.
=== Cannibalism === On 23 July 1988, Gibson ate the flesh of another person in public. Because England does not have a specific law against cannibalism, he legally ate a canapé of donated human tonsils in Walthamstow High Street, London. A year later, on 15 April 1989, he publicly ate a slice of human testicle. When he tried to eat another slice of human testicle as "hors d'oeuvre" at the Pitt International Galleries in Vancouver on 14 July 1989, the police confiscated the testicle. However, the charge of publicly exhibiting a disgusting object was dropped, and two months later he finally ate the piece of human testicle on the steps of the Vancouver court house.
Tulip festivals are held around the world, for example in the Netherlands and Spalding, England. There is also a popular festival in Morges, Switzerland. Every spring, there are tulip festivals in North America, including the Tulip Time Festival in Holland, Michigan, the Skagit Valley Tulip Festival in Skagit Valley, Washington, the Tulip Time Festival in Orange City and Pella, Iowa, and the Canadian Tulip Festival in Ottawa, Ontario, Canada. Tulips are also popular in Australia and several festivals are held in September and October, during the Southern Hemisphere's spring. The Indira Gandhi Memorial Tulip Garden in India hosts an annual tulip festival which draws huge attention and has an attendance of over 200,000.
=== Cultural aspects of exhumation === Frequently, cultures have different sets of exhumation taboos. Occasionally these differences result in conflict, especially in cases where a culture with more lenient exhumation rules wishes to operate on the territory of a different culture. For example, U.S. construction companies have run into conflict with Native American groups that have wanted to preserve their burial grounds from disturbance. In Southern Chinese culture, graves are opened after a period of years. The bones are removed, cleaned, dried, and placed in a ceramic pot for reburial (in Taiwan), or in a smaller coffin and to be reburied in another location (in Vietnam). The practice is called jiǎngǔ(撿骨) in Taiwan, or Bốc mộ(卜墓) in Vietnam "digging up bones" and is an important ritual in the posthumous "care" of children for their deceased parents and ancestors. Jewish law forbids the exhumation of a corpse. The majority of Muslim jurors maintain that an individual buried in a mosque must be exhumed and that offering prayers in such a mosque renders the prayer invalid. Jurists, however, hold that mosques built around already existing graves are to be demolished. In England and Wales once the top of a coffin has been lowered below ground level during a burial, raising the coffin again, for any reason, is considered exhumation regardless of the cause. Even if further work is necessary to properly fit the casket into the grave without further, the Home Office must to be notified and a full investigation undertaken.
Sources: en.wikipedia.org
KH-001 is an atypical serotonin reuptake inhibitor (SRI) and phosphodiesterase (PDE) inhibitor which is under development for the treatment of premature ejaculation. It is taken on-demand orally. The drug is a purified alkaloid derived from the South African plant Sceletium tortuosum (kanna). It is said to be selective and to have high potency as a serotonin reuptake inhibitor and phosphodiesterase inhibitor. In addition, KH-001 has atypical properties as a serotonin reuptake inhibitor, including a rapid onset of therapeutic effectiveness rather than requiring chronic administration. KH-001 has been found to increase latency to ejaculation in male rats treated acutely with para-chloroamphetamine (PCA) to induce ejaculation. The pharmacokinetics of KH-001 in humans have been studied. It showed a rapid onset and a short duration. The drug is described as a potential first-in-class medication. KH-001 is under development by Kadence Bio (formerly Kanna Health). As of November 2024, it is in phase 1 clinical trials. Phase 2 trials were planned to begin in 2025. The chemical structure of KH-001 does not yet appear to have been disclosed. However, Kanna Health patented synthetic analogues of mesembrine with activity as serotonin reuptake inhibitors in 2023, with KH-001 being indicated as one of the compounds in the patent.
=== 1980 === January 3–4: President Jimmy Carter withdraws the SALT II Treaty from Senate confirmation and bans technology sales to the Soviet Union. January 27: The Carter Doctrine commits the United States to defending the Gulf States from external invasion. February 13: Britain's MI6 commences its indirect and direct covert operations in Afghanistan, to support the Afghan mujahideen against Soviet intervention. February 25: A military coup occurred in Suriname eventually lead to the establishment of a military regime in the country. March 21: The United States and its allies boycott the 1980 Summer Olympics (July 15 – August 3) in Moscow. April 17: Robert Mugabe becomes Prime Minister of Zimbabwe. April 30: Iranian Embassy in London is taken over by DRFLA militants starting a 6-day-long hostage situation. May 4: Josip Broz Tito, communist leader of Yugoslavia since 1945, dies at the age of 87 in Ljubljana. May 17: Peru begins experiences a civil conflict between the government and the Marxist–Leninist guerilla groups, most notably the Shining Path. May 18–27: An anti-government uprising occurred in Gwangju, South Korea. 3 July: the CIA begins Operation Cyclone - a program to arm and finance the Afghan mujahideen fighting the Soviets in Afghanistan. August 31: In Poland, the Gdańsk Agreement is signed after a wave of strikes which began at the Lenin Shipyards in Gdańsk. The agreement allows greater civil rights, such as the establishment of a trade union, known as Solidarity, independent of communist control.
Cloning of the YAP1 gene facilitated the identification of a modular protein domain, known as the WW domain. Two splice isoforms of the YAP1 gene product were initially identified, named YAP1-1 and YAP1-2, which differed by the presence of an extra 38 amino acids that encoded the WW domain. Apart from the WW domain, the modular structure of YAP1 contains a proline-rich region at the very amino terminus, which is followed by a TID (TEAD transcription factor interacting domain). Next, following a single WW domain, which is present in the YAP1-1 isoform, and two WW domains, which are present in the YAP1-2 isoform, there is the SH3-BM (Src Homology 3 binding motif). Following the SH3-BM is a TAD (transactivation domain) and a PDZ domain-binding motif (PDZ-BM) (Figure 1).
Sources: en.wikipedia.org
Dihydrocodeine, sold under the brand name Dicodin among others, is a semi-synthetic opioid analgesic prescribed for pain or severe dyspnea, or as an antitussive, either alone or compounded with paracetamol (acetaminophen) (as in co-dydramol) or aspirin. It was developed in Germany in 1908 and first marketed in 1911. Commonly available as tablets, solutions, elixirs, and other oral forms, dihydrocodeine is also available in some countries as an injectable solution for deep subcutaneous and intra-muscular administration. As with codeine, intravenous administration should be avoided, as it could result in anaphylaxis and life-threatening pulmonary edema. In the past, dihydrocodeine suppositories were used. Dihydrocodeine is available in suppository form on prescription. Dihydrocodeine is used as an alternative to codeine and similarly belongs to step 2 of the WHO analgesic ladder. It was first described in 1911 and approved for medical use in 1948. Dihydrocodeine was developed during the search for more effective cough medication, especially to help reduce the spread of tuberculosis, pertussis, and pneumonia in the years from c.a. 1895 to 1915. It is similar in chemical structure to codeine.
Geochronology is the science of determining the age of rocks, fossils, and sediments using signatures inherent in the rocks themselves. Absolute geochronology can be accomplished through radioactive isotopes, whereas relative geochronology is provided by tools such as paleomagnetism and stable isotope ratios. By combining multiple geochronological (and biostratigraphic) indicators the precision of the recovered age can be improved. Geochronology is different in application from biostratigraphy, which is the science of assigning sedimentary rocks to a known geological period via describing, cataloging and comparing fossil floral and faunal assemblages. Biostratigraphy does not directly provide an absolute age determination of a rock, but merely places it within an interval of time at which that fossil assemblage is known to have coexisted. Both disciplines work together hand in hand, however, to the point where they share the same system of naming strata (rock layers) and the time spans utilized to classify sublayers within a stratum. The science of geochronology is the prime tool used in the discipline of chronostratigraphy, which attempts to derive absolute age dates for all fossil assemblages and determine the geologic history of the Earth and extraterrestrial bodies.
== History, geography and ethnography == In West Africa, the bark, roots, leaves, flowers, fruits, and seeds are commonly used in traditional medicine to treat a wide diversity of complaints, both internally and externally, sometimes in combination with other medicinal plants. The bark is most important for medicinal uses, followed by the leaves. Medicinal applications include the treatment of parasitic infections, circulatory system disorders, such as arterial hypertension, and disorders of the respiratory system, digestive system and skin. In veterinary medicine, a root decoction is used to treat coccidiosis in poultry. Green pods are crushed and added to rivers to kill fish. The tree locust bean is also known as "arbre à farine, fern leaf, irú, monkey cutlass tree, two ball nitta-tree, nété and néré"). The use of fermented locust beans in West Africa was documented as early as the 14th century, and described by Michel Adanson in his Histoire naturelle du Sénégal, published in 1757. Geographically, Parkia biglobosa can be found in a belt stretching from the Atlantic coast in Senegal to southern Sudan and northern Uganda. The tree currently exists within a wide range of natural communities but is most abundant in anthropic communities – places where cultivation is semi-permanent. Annual production of seeds in northern Nigeria is estimated at around 200,000 t. While the products of the tree are not common in international trade, they form an important part of local and regional trade in West Africa.
Sources: en.wikipedia.org
PT-141 was the internal development code assigned to bremelanotide during preclinical research. Reference sources sometimes index the peptide under the code rather than the generic name. The two terms describe the same molecule.
They are related but distinct cyclic peptides. Melanotan II is an earlier and less selective melanocortin analog. Bremelanotide was developed later with a narrower receptor profile and a defined clinical application.
The reviewed product is given by subcutaneous injection using a single-use autoinjector. Administration occurs under prescription supervision. The device delivers one fixed amount per use rather than a measured or adjustable quantity.
MC4R is regarded as the primary mediator on the basis of binding and functional assays. Other subtypes are also engaged, which helps explain flushing and related side effects. The step from receptor activation to reported desire change remains partly inferential.